3rd Annual Sickle Cell Summit:
November 3rd and 4th, 2023
A virtual summit presented by the Sickle Cell Awareness Group of Ontario and partners from the Hospital for Sick Children, University Health Network, Hamilton Health Sciences, Queen’s University, University of Ottawa, and the Children’s Hospital of Eastern Ontario
What is the Sickle Cell Summit 2023?
The Sickle Cell Summit 2023 will be held virtually on November 3rd and 4th, 2023. The Summit offers an interactive and comprehensive agenda dedicated to improving the quality of life of individuals and families affected by sickle cell disease. It also provides opportunities for collaboration with the industry, policymakers, and multiple global stakeholders in the field of hematology.
Recordings from the 2022 Ontario Sickle Cell Summit are available through the Sickle Cell Awareness Group of Ontario here (https://sicklecellanemia.ca/summit-2022).
SUMMIT DELIVERY PLATFORM
The Sickle Cell Summit 2023 will be delivered online over a virtual platform.
Abstracts will be accepted for presentations in the following formats:
Plenary sessions are 60 minutes long and must address a topic relevant to summit delegates. A plenary session may involve a panel or a single presenter.
Tracked Speaker Sessions
Speaker sessions are 75 minutes long and provide perspectives on a topic relevant to summit delegates. Sessions can include a maximum of 4 experts, plus a moderator. A moderator for the session is to be identified in the abstract. Abstracts must indicate if identified panelists are proposed or confirmed. Preference will be given to abstracts with confirmed panelists. Panel abstracts with proposed panelists may be given provisional approval subject to the confirmation of all panelists.
A poster presentation can be a good way to present targeted research or significant work in progress. E-posters will be displayed in the e-poster gallery for the duration of the Summit.
WHO SHOULD SUBMIT AN ABSTRACT?
As a patient-focused conference, presentations are welcome from:
Healthcare providers, Clinicians, and Health Care Provider Associations
Researchers (from non-profit organizations, universities, and other settings)
People with lived SCD experience (patients, caregivers, and patient organizations)
Policymakers and Government Agencies
Authors must indicate their institution, organization, city, state, and country. Any conflict of interest and financial support of studies should be disclosed.
Preference Will Be Given to Abstracts That:
Support the Summit theme
are relevant to the Summit audience
are submitted in English or French language
are of high quality (appropriate methodology, completeness of results, appropriate length of 250-300 words, appropriate wording) and are clear and easy to understand
are innovative or add to an existing body of knowledge
contains no more than 2 figures
includes a brief introduction, the aim of the study, methods, results, and conclusion
Have all presenters and moderators identified and confirmed
Clinical Learning themes
Cannabis And Sickle Cell Care
Acute And Chronic Pain Management (Could Include Ketamine, Virtual Reality)
Advancing treatments and therapies for sickle cell disease on a global level
Transfusion Medicine In SCD
Pharmacotherapy And Sickle Cell Care
Advocacy For Healthcare Providers
Advocacy for Novel Therapies: What Health Care Providers Need to Know
Gene Therapy for SCD in Canada
Beyond Hydroxyurea: Other Emerging Therapies
Advocacy Learning themes
Depression, Anxiety, and the Neurodiversity of Sickle Cell Disease
Racism, health equity, and microaggressions
Role of Patient Organization
Non-pharmacological Pain Management
Navigating Relationships In SCD
Arts-Based Facilitated Learning
Workplace And School Supports
Employer Response to Sickle Cell (Accommodation/Labour Rights)/Disability Justice
Psycho-social Learning themes
Depression, Anxiety, and the Neurodiversity of Sickle Cell Disease
Community SCD Resources
Racism, Health Equity, And Microaggressions
Social Workers As Partners And Advocates
Accessing Financial Supports (E.G., Disability Benefits, Medication Benefits, Dental Care, Physio)
Mental Health Intersectionality (Neurodiversity and Sickle Cell)
Patient – Finding Love
Patient – Self Management Tools and digital tools for self-care
Family – Family Planning
Family – Caring For Yourself
Gene Editing and Other Curative Therapies in Sickle Cell Disease
Safe, Pheno-type matched Blood
Acute Chest Syndrome and Sickle Cell Disease
What is hot in Sickle Cell Disease
Priapism and sickle cell disease
Pregnancy and SCD
Abstracts must be submitted online using the abstract submission form. The maximum length of an abstract is 300 words. We do not require a specific format for abstracts. However, the abstract text should be clear and easy to understand.
The abstract submission form includes fields for the following required information:
Title — one that clearly identifies your presentation
Submission contact — name, title, organization, contact information
Presentation format — submitted abstracts will only be considered for presentation in the selected format
Intended audience — who you want to reach with your presentation
Purpose or educational objective — what attendees will leave with
Presenters — names, titles, organizations, contact information, confirmed or proposed status; please provide a brief (65 words maximum) narrative biography and picture (JPEG format, minimum of 200 KB) for each presenter
Authors — names, titles, organizations, contact information; photos and biographies are not required for co-authors unless they are also presenting
Panel moderator, if applicable — name, title, organization, contact information
Speaker disclosure and conflict of interest.
This information does not count toward the 250-word abstract text total.’
All submissions received by July 31, 2023, will be reviewed by members of the Summit organizing committee. Successful submissions will be selected based on relevance to the topic themes, and perceived level of interest to the summit audience.
SPEAKER DECLARATIONS/CONFLICT OF INTEREST
Individual speaker declarations identifying all actual or potential conflicts of interest in relation to the program, topic, or presentation must be disclosed when submitting an abstract. For each speaker, either of the following is required:
a declaration that the speaker has no actual or potential conflict in relation to the program, topic, or presentation
a declaration of a competing interest or affiliation that could be perceived as having a bearing on the program, topic, or presentation; and a listing of all current competing interests or affiliations.
Abstracts must be received by 11:00 p.m. on Thursday, August 31, 2023.